Research Figures
Data from the Scientific Report 2022
- 525 Projects
- 406 Clinical Trials
- 816 Publications
- 5563 Total Impact Factor
News
Psychosis research reaches educational centers
The Patient Engagement in Research Area of the Institut de Recerca Sant Joan de Déu (IRSJD) has launched an educational initiative aimed at 3rd and 4th year ESO students to address mental health, contribute to the reduction of prejudices and stigmas, and promote the recognition of risk factors associated with psychotic disorders, also promoting early detection and prevention in the face of any warning signs.
Bellvitge and Sant Joan de Déu identify the genetic variants associated with the most severe forms of Stargardt’s disease
Stargardt's disease is a rare disease that causes the loss of central vision, progressively and irreversibly. It is usually diagnosed before the age of 20 and it is very difficult to predict the evolution of patients: some may worsen very quickly while in others the disease progresses slowly.
Interviews
Susana Ochoa Güerre
Psychologist, head of the Research Group on Etiopathogenesis and Treatment of Severe Mental Disorders (MERITT) at the Institut de Recerca Sant Joan de Déu (IRSJD) and head of research at the Parc Sanitari Sant Joan de Déu (PSSJD).
Agenda
Next Generation Non-Invasive, Multi-Modal Neuroimagers and Neuromonitors Based on Near-Infrared Light: Applications and Examples
El Institut de Recerca Sant Joan de Déu reanuda su tradicional Ciclo de Seminarios Científicos del IRSJD, una actividad que durante años ha sido un espacio clave de encuentro, intercambio y debate para toda la comunidad investigadora del centro.
Modeling Rare Renal Pathologies: From ClC-5 Dysfunction to Novel Therapeutics in Dent’s Disease
El Institut de Recerca Sant Joan de Déu resumes its traditional Scientific Seminar Cycle, an activity that for years has been a key space for meeting, exchange and debate for the entire research community of the center.